Infinity Pharmaceuticals Probability of Future Stock Price Finishing Over 1.91

INFIDelisted Stock  USD 0.04  0.03  42.86%   
Infinity Pharmaceuticals' future price is the expected price of Infinity Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Infinity Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
  
Please specify Infinity Pharmaceuticals' target price for which you would like Infinity Pharmaceuticals odds to be computed.

Infinity Pharmaceuticals Target Price Odds to finish over 1.91

The tendency of Infinity Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 1.91  or more in 90 days
 0.04 90 days 1.91 
close to zero percent
Based on a normal probability distribution, the odds of Infinity Pharmaceuticals to move over $ 1.91  or more in 90 days from now is close to zero percent (This Infinity Pharmaceuticals probability density function shows the probability of Infinity Stock to fall within a particular range of prices over 90 days) . Probability of Infinity Pharmaceuticals price to stay between its current price of $ 0.04  and $ 1.91  at the end of the 90-day period is about 98.0 .
Given the investment horizon of 90 days Infinity Pharmaceuticals has a beta of -2.46. This usually indicates as returns on its benchmark rise, returns on holding Infinity Pharmaceuticals are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Infinity Pharmaceuticals is expected to outperform its benchmark. Additionally Infinity Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   Infinity Pharmaceuticals Price Density   
       Price  

Predictive Modules for Infinity Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Infinity Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Infinity Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.040.04
Details
Intrinsic
Valuation
LowRealHigh
0.040.040.04
Details
Naive
Forecast
LowNextHigh
0.020.020.02
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.020.050.09
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Infinity Pharmaceuticals. Your research has to be compared to or analyzed against Infinity Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Infinity Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Infinity Pharmaceuticals.

Infinity Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Infinity Pharmaceuticals is not an exception. The market had few large corrections towards the Infinity Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Infinity Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Infinity Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-1
β
Beta against NYSE Composite-2.46
σ
Overall volatility
0.05
Ir
Information ratio -0.11

Infinity Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Infinity Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Infinity Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Infinity Pharmaceuticals is not yet fully synchronised with the market data
Infinity Pharmaceuticals has some characteristics of a very speculative penny stock
Infinity Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 2.59 M. Net Loss for the year was (44.37 M) with loss before overhead, payroll, taxes, and interest of (31.38 M).
Infinity Pharmaceuticals currently holds about 56.58 M in cash with (42.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from investorplace.com: 7 Struggling Semiconductor Stocks to Sell in March

Infinity Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Infinity Stock often depends not only on the future outlook of the current and potential Infinity Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Infinity Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding89.2 M
Cash And Short Term Investments38.3 M

Infinity Pharmaceuticals Technical Analysis

Infinity Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Infinity Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Infinity Pharmaceuticals. In general, you should focus on analyzing Infinity Stock price patterns and their correlations with different microeconomic environments and drivers.

Infinity Pharmaceuticals Predictive Forecast Models

Infinity Pharmaceuticals' time-series forecasting models is one of many Infinity Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Infinity Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Infinity Pharmaceuticals

Checking the ongoing alerts about Infinity Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Infinity Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Infinity Pharmaceuticals is not yet fully synchronised with the market data
Infinity Pharmaceuticals has some characteristics of a very speculative penny stock
Infinity Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 2.59 M. Net Loss for the year was (44.37 M) with loss before overhead, payroll, taxes, and interest of (31.38 M).
Infinity Pharmaceuticals currently holds about 56.58 M in cash with (42.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from investorplace.com: 7 Struggling Semiconductor Stocks to Sell in March
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
Note that the Infinity Pharmaceuticals information on this page should be used as a complementary analysis to other Infinity Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Infinity Stock

If you are still planning to invest in Infinity Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Infinity Pharmaceuticals' history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance